Research brief · Longevity
Cartalax
Ala-Glu-Asp cartilage bioregulator peptide used in joint and cartilage aging research models.
Class
Khavinson short-chain peptide bioregulator
Half-life
Short (minutes in plasma; tissue-targeted signalling)
Studied in
Cartilage biology, joint tissue aging, chondrocyte gene expression studies.
What it is
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) from the Khavinson family of short-chain peptide bioregulators, originally derived from cartilage tissue extracts. In laboratory research it is studied for its putative epigenetic effects on chondrocyte differentiation and cartilage matrix gene expression.
Mechanism studied
Short peptide proposed to bind promoter regions of chondrocyte-associated genes, modulating cartilage cell gene expression in research models.
Research notes
- Belongs to the same Khavinson short-peptide family as Epithalon and Pinealon.
- Investigated alongside standard cartilage markers (COL2A1, aggrecan) in in-vitro chondrocyte studies.
- Strictly for laboratory research use — not for human or veterinary application.
Before sourcing any material
- Confirm a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity).
- Check the stated peptide content per vial, not just the gross vial mass.
- Plan reconstitution volumes first so the vial size matches your protocol.
- Verify what is lawful in your jurisdiction — these are in-vitro research reagents, not medicines.